{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:10:50Z","timestamp":1778832650428,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzen Municipality","doi-asserted-by":"publisher","award":["SZSM202411031"],"award-info":[{"award-number":["SZSM202411031"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.anndiagpath.2026.152637","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:19:49Z","timestamp":1772849989000},"page":"152637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Matrix-producing carcinoma of the breast frequently exhibits amplification of the c-MYC gene"],"prefix":"10.1016","volume":"83","author":[{"given":"Lu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mumin","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youquan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2026.152637_bb0005","series-title":"Breast Tumours. WHO Classification of Tumours","author":"WHO Classification of Tumours Editorial Board","year":"2019"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152637_bb0010","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0046-8177(89)90149-4","article-title":"Metaplastic carcinomas of the breast. I matrix-producing carcinoma","volume":"20","author":"Wargotz","year":"1989","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152637_bb0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31818ab26e","article-title":"Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma","volume":"33","author":"Downs-Kelly","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152637_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1066896909332732","article-title":"Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2\/neu-) cases","volume":"18","author":"Gwin","year":"2010","journal-title":"Int J Surg Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152637_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1440-1827.2011.02676.x","article-title":"Matrix-producing carcinoma of the breast in the Chinese population: a clinicopathological study of 13 cases","volume":"61","author":"Shui","year":"2011","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152637_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/03008916221080190","article-title":"A molecular reappraisal of matrix-producing breast metaplastic carcinoma highlighted by PLAG1 and MYC rearrangements","volume":"109","author":"Salvatori","year":"2023","journal-title":"Tumori"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152637_bb0035","doi-asserted-by":"crossref","first-page":"642","DOI":"10.5858\/arpa.2014-0200-OA","article-title":"Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options","volume":"139","author":"Ross","year":"2015","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.anndiagpath.2026.152637_bb0040","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s41379-022-01017-7","article-title":"Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma","volume":"35","author":"Stradella","year":"2022","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2026.152637_bb0045","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s41379-018-0081-z","article-title":"Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma","volume":"31","author":"Krings","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2026.152637_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1101\/sqb.2016.81.031153","article-title":"A time for MYC: metabolism and therapy","volume":"81","author":"Dang","year":"2016","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152637_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041038","article-title":"Structural and biophysical insights into the function of the intrinsically disordered Myc oncoprotein","volume":"9","author":"Beaulieu","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152637_bb0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front Med"},{"issue":"19","key":"10.1016\/j.anndiagpath.2026.152637_bb0065","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1038\/sj.onc.1202750","article-title":"The basic region\/helix-loop-helix\/leucine zipper domain of Myc proto-oncoproteins: function and regulation","volume":"18","author":"L\u00fcscher","year":"1999","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.anndiagpath.2026.152637_bb0070","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1128\/MCB.21.3.691-702.2001","article-title":"The Max network gone mad","volume":"21","author":"Baudino","year":"2001","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152637_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.11.013","article-title":"Myc Cooperates with Ras by Programming Inflammation and Immune Suppression","volume":"171","author":"Kortlever","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152637_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7150\/ijbs.51458","article-title":"MYC dysfunction modulates stemness and tumorigenesis in breast cancer","volume":"17","author":"Liu","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"10","key":"10.1016\/j.anndiagpath.2026.152637_bb0085","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1586\/14737140.8.10.1689","article-title":"MYC in breast tumor progression","volume":"8","author":"Chen","year":"2008","journal-title":"Expert Rev Anticancer Ther"},{"issue":"11","key":"10.1016\/j.anndiagpath.2026.152637_bb0090","doi-asserted-by":"crossref","first-page":"14479","DOI":"10.1007\/s13277-016-5349-7","article-title":"Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications","volume":"37","author":"Pourteimoor","year":"2016","journal-title":"Tumour Biol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2026.152637_bb0095","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1038\/sj.bjc.6601703","article-title":"Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses","volume":"90","author":"Blancato","year":"2004","journal-title":"Br J Cancer"},{"issue":"28","key":"10.1016\/j.anndiagpath.2026.152637_bb0100","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1200\/JCO.2006.06.6944","article-title":"The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer","volume":"24","author":"Ma","year":"2006","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.anndiagpath.2026.152637_bb0105","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152637_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7150\/ijbs.51458","article-title":"MYC dysfunction modulates stemness and tumorigenesis in breast cancer","volume":"17","author":"Liu","year":"2021","journal-title":"Int J Biol Sci"},{"issue":"12","key":"10.1016\/j.anndiagpath.2026.152637_bb0115","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/cells8121492","article-title":"MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance and applications in human triple-negative breast cancer","volume":"8","author":"Ding","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.anndiagpath.2026.152637_bb0120","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1042\/BST20191055","article-title":"Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis","volume":"48","author":"Lev","year":"2020","journal-title":"Biochem Soc Trans"},{"issue":"5578","key":"10.1016\/j.anndiagpath.2026.152637_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1071489","article-title":"Sustained loss of a neoplastic phenotype by brief inactivation of MYC","volume":"297","author":"Jain","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152637_bb0130","first-page":"10","article-title":"Strategies to Inhibit Myc and Their Clinical Applicability","volume":"23","author":"Whitfield","year":"2017","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152637_bb0135","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/cells9040883","article-title":"Blocking myc to treat cancer: reflecting on two decades of omomyc","volume":"9","author":"Mass\u00f3-Vall\u00e9s","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.anndiagpath.2026.152637_bb0140","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bbagrm.2014.03.005","article-title":"Small-molecule inhibitors of the Myc oncoprotein","volume":"1849","author":"Fletcher","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.anndiagpath.2026.152637_bb0145","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1158\/2159-8290.CD-19-0435","article-title":"MYC instructs and maintains pancreatic adenocarcinoma phenotype","volume":"10","author":"Sodir","year":"2020","journal-title":"Cancer Discov"},{"issue":"941","key":"10.1016\/j.anndiagpath.2026.152637_bb0150","article-title":"c-Myc-targeted therapy in breast cancer: A review of fundamentals and pharmacological Insights","volume":"15","author":"Stipp","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.anndiagpath.2026.152637_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.humpath.2018.10.021","article-title":"Microglandular adenosis is an advanced precursor breast lesion with evidence of molecular progression to matrix-producing metaplastic carcinoma","volume":"85","author":"Schwartz","year":"2019","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2026.152637_bb0160","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/jcp-2024-209833","article-title":"Carcinoma arising in microglandular adenosis of the breast: clinicopathological and genetic analysis","volume":"79","author":"Zhang","year":"2025","journal-title":"J Clin Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2026.152637_bb0165","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.21873\/anticanres.13536","article-title":"Matrix-producing carcinoma as an aggressive triple-negative breast cancer: clinicopathological features and response to neoadjuvant chemotherapy","volume":"39","author":"Shimada","year":"2019","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.anndiagpath.2026.152637_bb0170","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41379-019-0208-x","article-title":"Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy","volume":"32","author":"Han","year":"2019","journal-title":"Mod Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342600033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342600033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T07:38:27Z","timestamp":1778830707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109291342600033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":34,"alternative-id":["S109291342600033X"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152637","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Matrix-producing carcinoma of the breast frequently exhibits amplification of the c-MYC gene","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2026.152637","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152637"}}